(IN BRIEF) Swedish cleantech company Chromafora has secured a €22.5 million loan from the European Investment Bank (EIB) to advance its SELPAXT technology, which removes harmful PFAS chemicals from ...
Swedish cleantech company Chromafora has secured a €22.5 million loan from the European Investment Bank (EIB) to advance its SELPAXT technology ...
(IN BRIEF) Thales has introduced an advanced vehicle access solution combining digital car keys with the newly launched NFC CARd Key, designed to enhance convenience and security in the automotive ...
(IN BRIEF) The European Investment Fund (EIF) and Catalan Finance Institute (ICF) have signed a €40 million guarantee agreement under the InvestEU programme to support sustainability projects by SMEs ...
(IN BRIEF) Swedish cleantech company Chromafora has secured a €22.5 million loan from the European Investment Bank (EIB) to advance its SELPAXT technology, which removes harmful PFAS chemicals from ...
Thales has introduced an advanced vehicle access solution combining digital car keys with the newly launched NFC CARd Key, designed to enhance convenience and security in the automotive industry. The ...
(IN BRIEF) The European Investment Fund (EIF) and Catalan Finance Institute (ICF) have signed a €40 million guarantee agreement under the InvestEU programme to support sustainability projects by SMEs ...
Thales has introduced an advanced vehicle access solution combining digital car keys with the newly launched NFC CARd Key, designed to enhance convenience and security in the automotive industry. The ...
Roche has announced results from the Phase IIb PADOVA study evaluating prasinezumab in 586 individuals with early-stage Parkinson’s disease. While the primary endpoint of time to confirmed motor ...
Roche has announced results from the Phase IIb PADOVA study evaluating prasinezumab in 586 individuals with early-stage Parkinson’s disease. While the primary endpoint of time to confirmed motor ...
Thales has introduced an advanced vehicle access solution combining digital car keys with the newly launched NFC CARd Key, designed to enhance co ...
Roche has announced results from the Phase IIb PADOVA study evaluating prasinezumab in 586 individuals with early-stage Parkinson’s disease. Wh ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback